{"id":206280,"name":"THE WASHINGTON TAX & PUBLIC POLICY GROUP O/B/O ALLIANCE FOR BIOPHARMA","slug":"the-washington-tax-public-policy-group-obo-alliance-for-biopharma","state":"DC","country":"United States of America","description":"lobbying firm","totalSpending":155000,"filings":14,"yearlySpending":[{"year":2020,"income":35000},{"year":2021,"income":60000},{"year":2022,"income":40000},{"year":2023,"income":20000}],"issues":[{"code":"TAX","display":"Taxation/Internal Revenue Code"}],"firms":["DOMER CONSULTING, LLC"],"lobbyists":["REGINA MAHONY"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["Issues related to the taxation of the biopharmaceutical industry including international taxation","Issues related to corporate and international tax, including issues related to the taxation of manufacturing income and capital investment in the United States and Puerto Rico and issues related to th","Issues related to corporate and international tax, including issues related to rates, tax code section 951A, issues related to the taxation of manufacturing income and capital investment in the United","Issues related to corporate and international tax, including issues related to corporate tax rates, issues related to the taxation of foreign income, tax code sections 951A and 954(c)(6), issues relat","Issues related to corporate and international taxation, including issues related to corporate tax rates, issues related to the taxation of foreign income, including tax code sections 951A, 250 and 59A"]}